23andMe: a clinical trial for Immuno-oncology Antibody
SUNNYVALE, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) — 23andMe Holding Co. (“23andMe”)…
SUNNYVALE, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) — 23andMe Holding Co. (“23andMe”)…
Sensors based on 4D imaging radar can instantly identify falls, and prompt Alexa to…
Vinehealth, a 2018-founded, London-based digital health startup that’s built an app…
Launched in October for Breast Cancer Prevention Month, WHO's interactive chatbot t…
BOSTON – December 3, 2021 – Pear Therapeutics, Inc. (“Pear Therapeutics”), the…
PrecisionOS® has received a 510(k) clearance from the U.S. Food and Drug Administra…
Pear Therapeutics, Inc., the leader in developing and commercializing software-base…
Join YourCoach.Health for their second annual Global Health & Wellness Coaching…
Research Highlights: A novel software algorithm developed for wearable devices, …
Article originally posted on transcarent.com by Glen Tullman - Executive Chairman a…